Cargando…

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas

Anaplastic glioma is Grade III and the median overall survival is about 37.6 months. However, there are still other factors that affect the prognosis for anaplastic glioma patients due to variable overall survival. So we screened four-lncRNA signature (AGAP2-AS1, TPT1-AS1, LINC01198 and MIR155HG) fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wen, Yang, Fan, Zhang, Lu, Chen, Jing, Zhao, Zheng, Wang, Haoyuan, Wu, Fan, Liang, Tingyu, Yan, Xiaoyan, Li, Jiye, Lan, Qing, Wang, Jiangfei, Zhao, Jizong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363582/ https://www.ncbi.nlm.nih.gov/pubmed/27764782 http://dx.doi.org/10.18632/oncotarget.12624

Ejemplares similares

Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease
por: Wang, Wen, et al.
Publicado: (2017)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
por: Huang, Rui, et al.
Publicado: (2020)

Systematic analysis of lncRNA–miRNA–mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer
por: Fan, Chun-Ni, et al.
Publicado: (2018)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients
por: Ruan, Lingjuan, et al.
Publicado: (2018)

A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
por: Chen, Qiang, et al.
Publicado: (2021)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma
por: Zhao, Jingwei, et al.
Publicado: (2020)

Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2016)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients
por: Wang, Fangce, et al.
Publicado: (2018)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
por: Huang, Qian-Rong, et al.
Publicado: (2022)

LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC
por: Niu, Limin, et al.
Publicado: (2019)

The lncRNA Toolkit: Databases and In Silico Tools for lncRNA Analysis
por: Pinkney, Holly R., et al.
Publicado: (2020)

LncRNA ontology: inferring lncRNA functions based on chromatin states and expression patterns
por: Li, Yongsheng, et al.
Publicado: (2015)

A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma
por: Wu, Zhikang, et al.
Publicado: (2022)

Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2020)

A robust immune-related lncRNA signature for the prognosis of human colorectal cancer
por: Zhu, Gongmin, et al.
Publicado: (2022)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

A seven-lncRNA signature for predicting prognosis in breast carcinoma
por: Xu, Min, et al.
Publicado: (2021)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

lncRNA Gene Signatures for Prediction of Breast Cancer Intrinsic Subtypes and Prognosis
por: Zhang, Silu, et al.
Publicado: (2018)

Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
por: Li, Yongsheng, et al.
Publicado: (2015)

lncRNA expression signatures in response to enterovirus 71 infection
por: Yin, Zhixin, et al.
Publicado: (2013)

Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer
por: Lin, Zhiheng, et al.
Publicado: (2022)

Prognostic potential of lncRNA RHPN1-AS1 in glioma
por: Wu, Yong, et al.
Publicado: (2020)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3j1up4ajbr4p6r9eb31fdl3k4v